AQW051   Click here for help

GtoPdb Ligand ID: 7371

Synonyms: AQW 051 | AQW-051 | VQW 765 | VQW-765 | VQW765
Compound class: Synthetic organic
Comment: AQW051 is an α7 nicotinic acetylcholine receptor (nAChR) partial agonist from Novartis that was proposed as an oral treatment for cognitive deficits in schizophrenia, Alzheimer's, and Parkinson's diseases [1,3]. The structure was first disclosed during the March 2014 ACS meeting. AQW051 was later re-named as VQW-765 having been licensed to Vanda Pharmaceuticals.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 25.36
Molecular weight 294.17
XLogP 3.57
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1ccc(cc1)c1ccc(cn1)OC1CN2CCC1CC2
Isomeric SMILES Cc1ccc(cc1)c1ccc(cn1)O[C@H]1CN2CCC1CC2
InChI InChI=1S/C19H22N2O/c1-14-2-4-15(5-3-14)18-7-6-17(12-20-18)22-19-13-21-10-8-16(19)9-11-21/h2-7,12,16,19H,8-11,13H2,1H3/t19-/m0/s1
InChI Key NPDLTEZXGWRMLQ-IBGZPJMESA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
AQW051 demonstrates high affinity for nAChR α7 as a potent agonist [4]. Analogs have been published in a series of patents (but without SAR tables) including [2] where this is example B5.
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
nicotinic acetylcholine receptor α7 subunit Hs Agonist Agonist 7.6 pKi - 4
⤷ pKi 7.6 (Ki 2.7x10-8 M) [125I]α- bungarotoxin binding assay [4]